Cover Image
市場調查報告書

美國的心律管理設備市場未來展望

United States Cardiac Rhythm Management Devices Market Outlook to 2021

出版商 GlobalData 商品編碼 356611
出版日期 內容資訊 英文 119 Pages
訂單完成後即時交付
價格
Back to Top
美國的心律管理設備市場未來展望 United States Cardiac Rhythm Management Devices Market Outlook to 2021
出版日期: 2016年01月22日 內容資訊: 英文 119 Pages
簡介

本報告提供美國的心律管理 (CRM) 設備市場現狀與未來發展預測相關分析,整體市場規模 (以金額、數量為準) 的成果值、預測值,及市場價格趨勢,市場佔有率 (各流通管道、各企業),主要企業的概要與策略的資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 本報告概要
  • 心律管理設備市場分類
  • 分析對象市場定義

第3章 美國的心律管理設備市場

  • 市場收益額的成果值 (以金額為準,過去7年份)
  • 市場收益額的預測值 (以金額為準,今後9年份)
    • 心臟再同步化治療 (CRT) 市場市場收益額:成果值 (過去8年份)
    • 置入式除顫器 (ICD) 市場市場收益額:成果值 (過去8年份)
    • 心律調節器市場市場收益額:成果值 (過去8年份)
    • 心臟再同步化治療 (CRT) 市場市場收益額:預測值 (今後8年份)
    • 置入式除顫器 (ICD) 市場市場收益額:預測值 (今後8年份)
    • 心律調節器市場市場收益額:預測值 (今後8年份)
  • 市場規模的成果值 (以數量為準,過去7年份)
  • 市場規模的預測值 (以數量為準,今後9年份)
    • 心臟再同步化治療 (CRT) 市場市場規模:成果值 (過去8年份)
    • 置入式除顫器 (ICD) 市場市場規模:成果值 (過去8年份)
    • 心律調節器市場市場規模:成果值 (過去8年份)
    • 心臟再同步化治療 (CRT) 市場市場規模:預測值 (今後8年份)
    • 置入式除顫器 (ICD) 市場市場規模:預測值 (今後8年份)
    • 心律調節器市場市場規模:預測值 (今後8年份)
  • 平均價格 (總計16年份)
  • 各銷售管道的市場佔有率 (以金額為準)
  • 各企業的市場佔有率 (以金額為準)

第4章 主要企業概要

  • Medtronic plc
  • St. Jude Medical, Inc.
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG

第5章 心律管理設備的開發中產品

第6章 資本交易環境

  • 股票上市 (共2件)
  • 風險企業融資 (1件)

第7章 近來的市場趨勢

  • 來自企業的發表 (企業溝通) (共16件)
  • 公佈財報 (共22件)
  • 政府、公益相關 (1件)
  • 法規、規定相關 (共6件)
  • 其他主要動向 (共4件)
  • 產品新聞 (共2件)
  • 策略、產業計畫 (1件)

第8章 附錄

圖表一覽

目錄
Product Code: GDMECC1427DB

GlobalData's new report, "United States Cardiac Rhythm Management Devices Market Outlook to 2021", provides key market data on the United States Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Cardiac Rhythm Management Devices market.
  • Global corporate-level profiles of key companies operating within the United States Cardiac Rhythm Management Devices market.
  • Key players covered include Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Cardiac Rhythm Management Devices Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Cardiac Rhythm Management Devices Market, United States

  • 3.1. Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2007-2014
  • 3.2. Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2014-2021
    • 3.2.1. Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.3. Pacemakers Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.4. Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2014-2021
    • 3.2.5. Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2014-2021
    • 3.2.6. Pacemakers Market, United States, Revenue ($m), by Segment, 2014-2021
  • 3.3. Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2007-2014
  • 3.4. Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2014-2021
    • 3.4.1. Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.2. Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.3. Pacemakers Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.4. Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2014-2021
    • 3.4.5. Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2014-2021
    • 3.4.6. Pacemakers Market, United States, Volume (Units), by Segment, 2014-2021
  • 3.5. Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2007-2021
  • 3.6. Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 3.7. Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in United States, Cardiac Rhythm Management Devices Market

  • 4.1. Medtronic plc
    • 4.1.1. Company Overview
  • 4.2. St. Jude Medical, Inc.
    • 4.2.1. Company Overview
  • 4.3. Boston Scientific Corporation
    • 4.3.1. Company Overview
  • 4.4. Biotronik SE & Co. KG
    • 4.4.1. Company Overview

5. Cardiac Rhythm Management Devices Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Equity Offerings
    • 6.1.1. Ventripoint Diagnostics to Raise up to USD0.3 Million in Private Placement of Units
    • 6.1.2. Ventripoint Diagnostics Raises USD2.3 Million in Private Placement of Units
  • 6.2. Venture Financing
    • 6.2.1. EBR Systems Raises USD20 Million in Venture Financing

7. Recent Developments

  • 7.1. Corporate Communications
    • 7.1.1. Dec 22, 2015: SurModics Announces Device Veteran Shawn McCormick Joins Board of Directors
    • 7.1.2. Nov 17, 2015: Proteus Digital Health Announces New Chairman of the Board and Chief Commercial Officer
    • 7.1.3. Nov 16, 2015: Konica Minolta to Start In Vitro Diagnostics Business in European and American Markets: SPFS Immunoassay System on Reference Exhibit at MEDICA 2015. in Germany
    • 7.1.4. Nov 04, 2015: Ventripoint Announces New Director and Provides Corporate Update
    • 7.1.5. Oct 20, 2015: Cardiac Science Files Chapter 11 Petition to Facilitate Debt Restructuring
    • 7.1.6. Oct 12, 2015: Orthopaedic Associates of Wisconsin and Blue Belt Technologies Announce First Surgery Center in Wisconsin to Implement CT-Free Robotic Orthopedic Surgery
    • 7.1.7. Oct 09, 2015: Dako, an Agilent Technologies Company, Announces FDA Approval of New Test for Lung Cancer Patients
    • 7.1.8. Aug 24, 2015: Daiichi Sankyo Obtains Approval in Japan for Supplementary Indication for "Artist Tablets"
    • 7.1.9. Jul 21, 2015: iRhythm Technologies Appoints Marga Ortigas-Wedekind Executive Vice President, Global Marketing
    • 7.1.10. Jul 02, 2015: BioTek Introduces Synergy Neo2 High Performance Multi-Mode Microplate Reader
    • 7.1.11. Jun 25, 2015: Medtronic Names Geoff Martha Executive Vice President and President, Restorative Therapies Group
    • 7.1.12. May 13, 2015: iRhythm Expands Leadership Team with Appointment of Derrick Sung, Ph.D. as Executive Vice President of Global Strategy and Corporate Development
    • 7.1.13. May 04, 2015: Stereotaxis Elects Medical Device Industry Veteran Duane DeSisto to Board of Directors
    • 7.1.14. Mar 25, 2015: Ventripoint Announces Resignation of Director
    • 7.1.15. Mar 06, 2015: SurModics Announces New Board Chair
    • 7.1.16. Feb 05, 2015: SurModics Announces Gerald B. Fischer's Retirement from Board of Directors
  • 7.2. Financial Announcements
    • 7.2.1. Dec 18, 2015: BRILIQUE (ticagrelor) receives positive European Union CHMP opinion for extended treatment of patients with a history of heart attack
    • 7.2.2. Dec 18, 2015: Sarepta Therapeutics Announces FDA Advisory Committee Meeting to Review Eteplirsen as a Treatment for Duchenne Muscular Dystrophy Amenable to Exon 51. Skipping
    • 7.2.3. Nov 10, 2015: SurModics Reports Fourth Quarter Fiscal 2015 Results
    • 7.2.4. Nov 03, 2015: Orthofix International Reports Third Quarter 2015 Financial Results
    • 7.2.5. Oct 22, 2015: Bard Announces Third Quarter Results
    • 7.2.6. Oct 01, 2015: Over 2000 Patients Treated with Ellipse Technologies' MAGEC System
    • 7.2.7. Sep 30, 2015: MediWound Awarded BARDA Contract Valued Up to $112 Million for Development and Procurement of NexoBrid for the U.S.
    • 7.2.8. Aug 20, 2015: New type of trial shows promise for several cancers
    • 7.2.9. Aug 05, 2015: SurModics Reports Third Quarter Fiscal 2015 Results
    • 7.2.10. Aug 04, 2015: Stereotaxis Reports 2015 Second Quarter Financial Results
    • 7.2.11. Jul 23, 2015: Bard Announces Second Quarter Results
    • 7.2.12. Jun 02, 2015: Medtronic Reports Fourth Quarter and Fiscal Year 2015 Financial Results
    • 7.2.13. May 19, 2015: Medtronic Announces Preliminary Fourth Quarter and Fiscal Year 2015 Revenue Results
    • 7.2.14. May 06, 2015: Stereotaxis Reports 2015 First Quarter Financial Results
    • 7.2.15. Apr 30, 2015: SurModics Reports Second Quarter Fiscal 2015 Results
    • 7.2.16. Apr 23, 2015: Bard Announces First Quarter Results
    • 7.2.17. Apr 17, 2015: Bionomics Showcases BNC101 Oncology Drug Development Program at 2015 AACR Annual Meeting
    • 7.2.18. Mar 11, 2015: The Medicines Company Provides new data on MDCO-216 at 2015 American College of Cardiology Scientific Sessions in San Diego
    • 7.2.19. Feb 25, 2015: Stereotaxis Reports 2014 Fourth Quarter and Full Year Financial Results
    • 7.2.20. Jan 29, 2015: SurModics Reports First Quarter Fiscal 2015 Results
    • 7.2.21. Jan 29, 2015: Bard Announces Fourth Quarter Results
    • 7.2.22. Jan 13, 2015: European Medicines Agency Grants Positive Opinion for Orphan Drug Status for Ovarian Cancer Oncolytic Vaccine
  • 7.3. Government and Public Interest
    • 7.3.1. Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean
  • 7.4. Legal And Regulatory
    • 7.4.1. Jan 05, 2016: LivaNova Provides Update on FDA Warning Letter
    • 7.4.2. Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury's Notice 2015-79
    • 7.4.3. Jul 21, 2015: FDA Issues Warning Letter To C. R. Bard
    • 7.4.4. Apr 02, 2015: Medtronic To Pay $4.41 Million To Resolve Allegations That It Unlawfully Sold Medical Devices Manufactured Overseas
    • 7.4.5. Feb 06, 2015: Medtronic to Pay $2.8 Million to Resolve False Claims Act Allegations Related to "SubQ Stimulation" Procedures
    • 7.4.6. Jan 13, 2015: Ventripoint Announces Completion of Initial Establishment Inspection by FDA
  • 7.5. Other Significant Developments
    • 7.5.1. Nov 18, 2015: iRhythm Technologies Launches New iOS App Enabling Patients to Report Irregular Heartbeat Symptoms for Physician Diagnosis
    • 7.5.2. Mar 30, 2015: Ventripoint Announces Distribution Partner for Military and VA Medical Centers
    • 7.5.3. Feb 19, 2015: Helius Medical Enrols First Patients In Multiple Sclerosis Feasibility Trial Of PoNS Device
    • 7.5.4. Jan 12, 2015: Medtronic Awards $150,000 Locally in Health Access Grants
  • 7.6. Product News
    • 7.6.1. Dec 22, 2015: FDA Approves BIOTRONIK Iperia ICD Systems with Full-Body ProMRI Technology
    • 7.6.2. Jan 26, 2015: SCS Introduces the Precisioncoat V Conformal Coating System
  • 7.7. Strategy And Business Planning
    • 7.7.1. Mar 30, 2015: Stereotaxis Extends Silicon Valley Bank Credit Facility by Three Years

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Market Modeling and Forecasting
    • 8.1.5. Company Share Analysis
    • 8.1.6. Distribution Share Analysis
  • 8.2. Expert Panel
  • 8.3. GlobalData Consulting
  • 8.4. Contact Us
  • 8.5. Disclaimer

List of Tables

  • Table 1: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 4: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: Pacemakers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 6: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 7: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 8: Pacemakers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 9: Cardiac Rhythm Management Devices Market, United States, Volume (Units), Historic, 2007-2014
  • Table 10: Cardiac Rhythm Management Devices Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 11: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), Historic, 2007-2014
  • Table 12: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), Historic, 2007-2014
  • Table 13: Pacemakers Market, United States, Volume (Units), Historic, 2007-2014
  • Table 14: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 15: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 16: Pacemakers Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 17: Cardiac Rhythm Management Devices Market, United States, Average Price ($) Historic, 2007-2014
  • Table 18: Cardiac Rhythm Management Devices Market, United States, Average Price ($), Forecast, 2014-2021
  • Table 19: Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 20: Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 21: Cardiac Rhythm Management Devices Market Pipeline Products
  • Table 22: Ventripoint Diagnostics to Raise up to USD0.3 Million in Private Placement of Units
  • Table 23: Ventripoint Diagnostics Raises USD2.3 Million in Private Placement of Units
  • Table 24: EBR Systems Raises USD20 Million in Venture Financing
  • Table 25: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

List of Figures

  • Figure 1: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 4: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 5: Pacemakers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 8: Pacemakers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 9: Cardiac Rhythm Management Devices Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 10: Cardiac Rhythm Management Devices Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 11: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 12: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 13: Pacemakers Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 14: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 15: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 16: Pacemakers Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 17: Cardiac Rhythm Management Devices Market, United States, Company Share (%) 2014
  • Figure 18: GlobalData Epidemiology-Based Forecasting Model
  • Figure 19: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 20: Primary Interviews by Participant Type (%)
Back to Top